Covered recipient · General Payments record
ANTHONY K LEUNG
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$5,724.98
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $917.91 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $309.00 | 6 |
| BOSTON SCIENTIFIC CORPORATION | $244.76 | 3 |
| Abbott Laboratories | $238.93 | 5 |
| Nevro Corp. | $97.67 | 1 |
| Avanos Medical | $27.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.30 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124897933 | CMS |
| Abbott Laboratories | $10.54 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124897935 | CMS |
| Abbott Laboratories | $8.43 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124897937 | CMS |
| Abbott Laboratories | $108.41 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124897939 | CMS |
| Abbott Laboratories | $90.25 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124897941 | CMS |
| Avanos Medical | $27.55 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149307013 | CMS |
| Boston Scientific Corporation | $31.95 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092742179 | CMS |
| Boston Scientific Corporation | $171.02 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092742183 | CMS |
| Boston Scientific Corporation | $41.79 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092742181 | CMS |
| Medtronic, Inc. | $33.39 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117176041 | CMS |
| Medtronic, Inc. | $147.77 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117176044 | CMS |
| Medtronic, Inc. | $64.26 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117176049 | CMS |
| Medtronic, Inc. | $14.56 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117176052 | CMS |
| Medtronic, Inc. | $10.21 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117176057 | CMS |
| Medtronic, Inc. | $38.81 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117176061 | CMS |
| Nevro Corp. | $97.67 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130752405 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.